Videos

ctDNA-Guided Therapy May Improve Breast Cancer Outcomes

June 18th 2025, 1:00pm

Video

For patients with metastatic HR+/HER2— breast cancer, there were various trials to have come out of ASCO 2025 that are worth keeping your eye on.

Zanzalintinib Triplet Combo Under Investigation in Kidney Cancer Subgroups

June 17th 2025, 8:00pm

Video

Treatment with zanzalintinib plus Opdivo and Opdualag is an option worth exploring in patients with previously untreated clear cell renal cell carcinoma

New Treatment Options Emerging Across Lung Cancer Subtypes

June 17th 2025, 1:00pm

Video

Both non-small lung cancer and small cell lung cancer is a disease that now has various therapeutic options available, according to experts.

Understanding the Whole Person Behind their Cancer Diagnosis

June 16th 2025, 8:00pm

Video

Dr. Joshua K. Sabari and Jackie Herigodt sat down to discuss the importance of knowing a patient beyond their cancer diagnosis.

Delving Into Brain Cancer Treatment Takeaways Following ASCO 2025

June 16th 2025, 1:00pm

Video

The de-escalation of therapy helps avoid unnecessary toxicity from treatment in patients with brain cancer, explained Drs. Joshua K. Sabari and Manmeet Singh Ahluwalia.

Breaking Down the VERIFY Trial for Patients With Polycythemia Vera

June 13th 2025, 8:00pm

Video

Dr. Aaron Gerds breaks down the outcomes of the phase 3 VERIFY trial, investigating rusfertide, for patients with polycythemia vera, a type of blood cancer.

What Should Patients With Lung Cancer Know After ASCO 2025?

June 13th 2025, 1:16pm

Video

Dr. Joshua K. Sabari and Dr. Prantesh Jain delve into key lung cancer outcomes from the 2025 ASCO Meeting that patients should be aware of.

Bringing Light to More Personalized Medicine in Lung Cancer After ASCO 2025

June 12th 2025, 8:00pm

Video

Expert oncologists Dr. Joshua K. Sabari and Dr. Eric K. Singhi break down key updates and takeaways in lung cancer treatment following ASCO 2025.

A New Therapeutic Approach May Make Waves in Kidney Cancer Treatment

June 12th 2025, 1:00pm

Video

Dr. Michael Serzan provides expert takeaways on treatment updates for patients with early-stage kidney cancer following the 2025 ASCO Meeting.

What Patients With Genitourinary Cancers Should Know After ASCO 2025

June 11th 2025, 8:00pm

Video

Dr. Joshua K. Sabari sat down with Dr. Daniel V. Araujo to discuss topline takeaways from the 2025 ASCO Meeting across the realm of genitourinary oncology